We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Octopus Group

Download Mobile App





MedLab Middle East Continues as World's Largest Attended Laboratory Exhibition and Conference

By LabMedica International staff writers
Posted on 05 Feb 2018
Print article
Image: MEDLAB Middle East continues to be the largest attended laboratory and IVD exhibition and conference in the world (Photo courtesy of MEDLAB).
Image: MEDLAB Middle East continues to be the largest attended laboratory and IVD exhibition and conference in the world (Photo courtesy of MEDLAB).
MEDLAB Middle East, held a week after Arab Health, continued to be the largest attended laboratory and IVD exhibition and conference in the world. Held from February 5-8, 2018, the annual laboratory meeting saw its second year as a stand-alone show and welcomed over 600 exhibitors and more than 25,000 attendees from 129+ countries.
 
MEDLAB is the flagship exhibition and congress of the MEDLAB Series portfolio, a collection of leading laboratory and diagnostics exhibitions and conferences worldwide, spanning across the Middle East, Asia, East/West Africa, Europe and the US. As the largest attended laboratory expo worldwide, MEDLAB stems from 15 years of growth alongside the MENA region's largest healthcare gathering, Arab Health.
 
MEDLAB Middle East held in Dubai, UAE, continued to expand in 2018 with the addition of two new halls and the capacity to showcase thousands of new products, equipment and services by the main players in the industry. Leading laboratory experts, scientists, researchers and clinicians converged at the three-day event to exchange and share their experiences and research results on all aspects of laboratory medicine and clinical research while companies showcased the latest innovations, products and cutting-edge technologies available in the IVD, medical laboratory and healthcare market.
 
At the heart of MEDLAB laboratory conference and exhibition lies the CME-accredited Congress featuring 17 CME-accredited conference tracks. Supported by the Cleveland Clinic, the MEDLAB conferences provide professionals with high-level CME credits. The MEDLAB Conferences cover a diverse range of subjects relating to laboratory management, microbiology, immunology, hematology, clinical chemistry and molecular diagnostics. With over 6,500 conference delegates in attendance from all over the world, the MEDLAB Congress is the ideal platform to come together and discover innovations in medical laboratory testing. MEDLAB Congress 2018 introduced new clinical tracks designed to enhance collaboration between laboratory professionals and clinicians. This will aid in accurate interpretation, quick reporting and diagnosis, therefore strengthening the laboratory’s ability to provide clinical decisions and improve the overall quality of service and care. 
 
This year’s MEDLAB Middle East also featured the Obs-Gyne Exhibition, which provided a platform for over 2,500 obstetricians, gynecologists, fertility specialists and family physicians to gather alongside 60+ of the industry's leading manufacturers to meet, exchange knowledge, share best practices and ultimately improve the level of patient care provided. Some of the key topics of discussion at the Obs-Gyne Exhibition were postpartum hemorrhage, androgen disorders in adolescents, psychological and sexual aspects in female genital cancer, early prediction and prevention of pre-eclampsia, obesity in pregnancy, treatment options for infertile women with uterine fibroids, and monitoring and delivery of the growth of restricted fetus.
 
The Poster Zone at the event displayed the latest research from laboratorians worldwide, promoting knowledge sharing and networking amongst MEDLAB’s delegates, who discussed the latest research, findings and developments within the industry. The Workshop Zone featured workshops hosted by leading laboratory and diagnostic companies who provided a hands-on approach towards utilizing the latest testing methods, findings and technology. MEDLAB Middle East also welcomed dealers and distributors from across the region as well as representatives from hospitals, consultancies and governments who took the opportunity to meet, do business with exhibitors and learn from all professionals within the healthcare and medical laboratory marketplace. 
 
New
Gold Supplier
Group A Streptococcus Antigen Test
OSOM Strep A Test
New
Alpha-1 Antitrypsin Deficiency Test
A1AT Genotyping Test
New
Squamous Cell Carcinoma Assay
CanAg SCC EIA
New
Fecal Bacterial Test
CLART EnteroBac

Print article

Channels

Clinical Chem.

view channel
Image: Brief schematic diagram of the detection principle and method (Photo courtesy of CAS)

Rapid, Non-Invasive Method Diagnoses Type 2 Diabetes by Sniffing Urinary Acetone

Over 90% of diabetes cases are attributed to Type 2 diabetes (T2D), a prevalent metabolic condition that is expected to impact 380 million individuals globally by 2025. Despite being highly accurate, the... Read more

Molecular Diagnostics

view channel
Image: Researchers have identified the origin of subset of autoantibodies that worsen lupus (Photo courtesy of Pexels)

Lupus Biomarker Testing Could Help Identify Patients That Need Early and Aggressive Treatment

Systemic lupus erythematosus (SLE) is an autoimmune disease that occurs when the body's antibodies, which usually protect against infections, attack healthy cells and proteins. These autoantibodies can... Read more

Immunology

view channel
Image: A genetic test could guide the use of cancer chemotherapy (Photo courtesy of Pexels)

Genetic Test Predicts Whether Bowel Cancer Patients Can Benefit From Chemotherapy

Late-stage bowel cancer patients usually undergo a series of chemotherapies and targeted medicines for cancer treatment. However, the responses to the last-line chemotherapy treatment trifluridine/tipiracil... Read more

Microbiology

view channel
Image: Use of DBS samples can break barriers in hepatitis C diagnosis and treatment for populations at risk (Photo courtesy of Pexels)

DBS-Based Assay Effective in Hepatitis C Diagnosis and Treatment for At Risk Populations

In a bid to eliminate viral hepatitis as a public health threat by 2030, the World Health Organization (WHO) has put forth a proposed strategy. To this end, researchers at the Germans Trias i Pujol Research... Read more

Pathology

view channel
Image: New research has opened a path for fast and accurate cancer diagnosis (Photo courtesy of Imagene)

AI-Based Image Analysis Software Profiles Cancer Biomarkers in Real Time

Lung cancer is the most widespread type of cancer worldwide, resulting in approximately 1.76 million fatalities annually. Non-small cell lung cancer (NSCLC) accounts for 85% of all lung cancer diagnoses... Read more

Technology

view channel
Image: Live view of non-fluorescent specimens using the glowscope frame (Photo courtesy of Winona State University)

Device Converts Smartphone into Fluorescence Microscope for Just USD 50

Fluorescence microscopes are utilized to examine specimens labeled with fluorescent stains or expressing fluorescent proteins, like those tagged with green fluorescent protein. However, since these microscopes... Read more

Industry

view channel
Image: The global antimicrobial resistance diagnostics market size is expected to reach USD 5.7 billion by 2028 (Photo courtesy of Pexels)

Global Antimicrobial Resistance Diagnostics Market Driven by Increasing Hospital-Acquired Infections

Antimicrobial drugs are intended to counteract the harmful effects of microbes and promote a healthy life. However, their excessive use can result in the development of resistance, commonly referred to... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.